Andere Sprachen Vicapsys Life Sciences, Inc.

Aktien

A2H60F

US92560A1060

VICP

Markt geschlossen - OTC Markets Andere Börsenplätze 16:29:14 10.05.2024			% 5 Tage	% 1. Jan.
0,444 ^USD	0,00 %		0,00 %	-83,80 %

2023	Vicapsys Life Sciences, Inc. meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 30. September 2023	CI
2023	Vicapsys Life Sciences, Inc. meldet Ergebnis für das zweite Quartal und die sechs Monate bis zum 30. Juni 2023	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Vicapsys Life Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14.11.
Vicapsys Life Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14.08.23
Vicapsys Life Sciences, Inc. announced that it has received $0.3036 million in funding	28.06.23
Vicapsys Life Sciences, Inc. announced that it expects to receive $0.3036 million in funding	27.06.23
Vicapsys Life Sciences : Change in Certifying Accountants - Form 8-K	17.05.23
VICAPSYS LIFE SCIENCES, INC. : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)	17.05.23
Vicapsys Life Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	15.05.23
VICAPSYS LIFE SCIENCES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	14.04.23
Vicapsys Life Sciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	14.04.23
Vicapsys Life Sciences, Inc. Auditor Raises 'Going Concern' Doubt	14.04.23
VICAPSYS LIFE SCIENCES, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	12.01.23
NOTE 2 - GOING CONCERN AND MANAGEMENT'S PLANS	21.11.22
Vicapsys Life Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	21.11.22
VICAPSYS LIFE SCIENCES, INC. : Change in Directors or Principal Officers (form 8-K)	28.09.22
Vicapsys Life Sciences, Inc. Announces Board Changes	28.09.22
Vicapsys Life Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	16.08.22
Vicapsys Life Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	13.05.22
Vicapsys Life Sciences, Inc. Appoints Federico Pier as Chief Executive Officer	12.04.22
VICAPSYS LIFE SCIENCES, INC. : Change in Directors or Principal Officers, Other Events, Financial Statements and Exhibits (form 8-K)	12.04.22
VICAPSYS LIFE SCIENCES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	16.03.22

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Vicapsys Life Sciences, Inc.

Aktien

A2H60F

US92560A1060

VICP

Andere Sprachen

Filter